Kronos Bio Stock Quote KRON - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

1.25

Bid

1.24

Ask

1.39

Volume

128,948

1.21 Day's Range 1.303

0.69 52 Week Range 2.22

Market Cap

75.118M

Previous Close

1.25

Open

1.24

Last Trade

1.24

Last Trade Time

Financial Volume

$ 161,683

VWAP

1.2539

Average Volume (3m)

454,290

Shares Outstanding

60,094,409

Dividend Yield

PE Ratio

-0.67

Earnings Per Share (EPS)

-1.87

Revenue

6.29M

Net Profit

-112.67M

Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription. Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.kronosbio.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Kronos Bio Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker KRON. The last closing price for Kronos Bio was $1.25. Over the last year, Kronos Bio shares have traded in a share price range of $ 0.69 to $ 2.22.

Kronos Bio currently has 60,094,409 shares outstanding. The market capitalization of Kronos Bio is $75.12 million. Kronos Bio has a price to earnings ratio (PE ratio) of -0.67.

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

— KB-0742 continues to demonstrate a manageable safety and tolerability profile with no grade 3/4 neutropenia observed — — KB-0742 continues to show dose linear pharmacokinetics up to 80mg...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.15	-10.7142857143	1.4	1.6	1.21	271127	1.42220485	CS
4	0.18	16.8224299065	1.07	1.6	0.93	268225	1.26867617	CS
12	0.2532	25.4012841091	0.9968	1.6	0.69	454290	1.04720893	CS
26	0.21	20.1923076923	1.04	1.6	0.69	400685	1.07000217	CS
52	-0.93	-42.6605504587	2.18	2.22	0.69	301009	1.11056142	CS
156	-21.11	-94.4096601073	22.36	25.01	0.69	304424	4.42761775	CS
260	-27.04	-95.5814775539	28.29	39.605	0.69	294512	8.67066355	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MIRAMIRA Pharmaceuticals Inc	$ 5.01 (627.35%)	158.14M
CMAXCareMax Inc	$ 5.19 (228.48%)	102.64M
NUKKNukkleus Inc	$ 0.499 (55.94%)	26.2M
SNOASonoma Pharmaceuticals Inc	$ 0.423 (37.34%)	4.88M
ONDSOndas Holdings Inc	$ 1.1297 (34.06%)	2.19M
CGBSCrown LNG Holdings Ltd	$ 0.9902 (-29.77%)	3.29M
LGCBLinkage Global Inc	$ 3.7833 (-27.45%)	166.7k
SPECSpectaire Holdings Inc	$ 0.395 (-24.76%)	1.78M
GSUNGolden Sun Health Technology Group Ltd	$ 5.07 (-24.55%)	155.37k
SLNASelina Hospitality PLC	$ 0.0364 (-23.04%)	75.77M
NVDANVIDIA Corporation	$ 123.45 (4.68%)	221.22M
SQQQProShares UltraPro Short QQQ	$ 8.08 (-4.49%)	176.65M
MIRAMIRA Pharmaceuticals Inc	$ 5.01 (627.35%)	151.42M
SERVServe Robotics Inc	$ 8.7192 (15.49%)	148.59M
NCPLNetcapital Inc	$ 0.1105 (6.25%)	121.97M